Company: GMRE
Filing Date: 2025-11-18
Form Type: 8-A12B
Source: 0001104659-25-113679
Chunk: 1

Company: Global Medical REIT Inc.
Filing Date: 2025-11-18
Form: 8-A12B
Chunk 1
---
 Exchange Commission (the “Commission”) on November 14, 2025, pursuant to
Rule 424(b) under the Securities Act of 1933, as amended, and under the heading “Description of Capital Stock”
in the accompanying prospectus that constitutes a part of the Company’s Registration Statement on Form S-3 (File
No. 333-276248), which was filed by the Registrant with the Commission on December 22, 2023, as amended by Post-Effective
Amendment No. 1 filed with the Commission on February 27, 2024 and as further amended by Post-Effective Amendment
No. 2 filed with the Commission on February 29, 2024 and declared effective on April 4, 2024, shall be deemed to be incorporated herein by reference.

| Item 2. | Exhibits. |

| Exhibit No. 
 3.1         
 3.2         |     | Description                                                                                                                        
 Articles                                                                                                                           
 of Restatement of Global Medical REIT Inc. (incorporated herein by reference to Exhibit 3.1                                        
 to the Company’s Report on Form 10-Q as filed with the Commission on August 8, 2018).                                              
 Articles of Amendment of Global Medical REIT Inc. (incorporated herein by reference to Exhibit 3.1 to the Company’s Current Report 
 on Form 8-K as filed with the Commission on September 19, 2025).                                                                   |
|:------------|:----|:-----------------------------------------------------------------------------------------------------------------------------------|
| 3.3         |     | Articles Supplementary for Global Medical                                                                                          
 REIT Inc. 8.00% Series B Cumulative Redeemable Preferred Stock (incorporated herein by reference to Exhibit 3.1                    
 to the Company’s Current Report on Form 8-K as filed with the Commission on November 18, 2025).                                    |
| 3.4         |     | Fourth Amended and Restated Bylaws of                                                                                              
 Global Medical REIT Inc., adopted as of December 7, 2022 (incorporated herein by reference to Exhibit 3.2                          
 to the Company’s Current Report on Form 8-K as filed with the Commission on December 7, 2022).                                     |
| 4.1         |     | Specimen of Common Stock Certificate                                                                                               
 (incorporated herein by reference to Exhibit 4.1 to the Company’s Registration Statement on Form S-11/A